1. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China 
Dr Yu Fang, PhD, Anita K Wagner, DrPH, Shimin Yang, BS, Minghuan Jiang, MS, Fang Zhang, PhD, Dennis Ross-Degnan, ScD 
The Lancet Global Health 
Volume 1, Issue 4, Pages e227-e237 (October 2013)
DOI: /S X(13)70072-X
Copyright © 2013 Fang et al. Open Access article distributed under the terms of CC BY-NC-ND Terms and Conditions

2. Figure 1
Change in availability of 44 medicines in the public sector from 2010 to 2012
LPG=lowest-priced generic. NEML=2009 National Essential Medicines List. OB=original brand. PL=2010–12 Shaanxi provincial medicines procurement list.
The Lancet Global Health 2013 1, e227-e237DOI: ( /S X(13)70072-X)
Copyright © 2013 Fang et al. Open Access article distributed under the terms of CC BY-NC-ND Terms and Conditions

3. Figure 2
Change in availability of 44 medicines in the private sector from 2010 to 2012
LPG=lowest-priced generic. NEML=2009 National Essential Medicines List. OB=original brand. PL=2010–12 Shaanxi provincial medicines procurement list.
The Lancet Global Health 2013 1, e227-e237DOI: ( /S X(13)70072-X)
Copyright © 2013 Fang et al. Open Access article distributed under the terms of CC BY-NC-ND Terms and Conditions